Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene M A Glasgow

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Respiratory Medicine|July 14, 2022
Epithelial damage in the cystic fibrosis lung: the role of host and microbial factorsArlene M A Glasgow, Catherine M Greene
Biochemical Society Transactions|May 11, 2018
Non-coding RNA in cystic fibrosisArlene M A Glasgow, Chiara De Santi, Catherine M Greene
International Journal of Molecular Sciences|February 5, 2020
Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic FibrosisAlison M D Hunt, Arlene M A Glasgow, Hilary Humphreys, et al.
Frontiers in Genetics|December 6, 2021
miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis MonocytesPaul J McKiernan, Kevin P Molloy, Arlene M A Glasgow, et al.
Experimental Parasitology|February 13, 2022
Helminth antigens modulate human PBMCs, attenuating disease progression in a humanised mouse model of graft versus host diseaseMarc Healy, Allison Aldridge, Arlene M A Glasgow, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2022
Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic FibrosisClaudie Gabillard-Lefort, Michelle Casey, Arlene M A Glasgow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2014
A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammationDonna M Small, Marie-Louise Zani, Derek J Quinn, et al.
Thorax|March 15, 2015
A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lungArlene M A Glasgow, Donna M Small, Aaron Scott, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Respiratory Medicine|July 14, 2022
Epithelial damage in the cystic fibrosis lung: the role of host and microbial factorsArlene M A Glasgow, Catherine M Greene
Biochemical Society Transactions|May 11, 2018
Non-coding RNA in cystic fibrosisArlene M A Glasgow, Chiara De Santi, Catherine M Greene
International Journal of Molecular Sciences|February 5, 2020
Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic FibrosisAlison M D Hunt, Arlene M A Glasgow, Hilary Humphreys, et al.
Frontiers in Genetics|December 6, 2021
miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis MonocytesPaul J McKiernan, Kevin P Molloy, Arlene M A Glasgow, et al.
Experimental Parasitology|February 13, 2022
Helminth antigens modulate human PBMCs, attenuating disease progression in a humanised mouse model of graft versus host diseaseMarc Healy, Allison Aldridge, Arlene M A Glasgow, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2022
Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic FibrosisClaudie Gabillard-Lefort, Michelle Casey, Arlene M A Glasgow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2014
A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammationDonna M Small, Marie-Louise Zani, Derek J Quinn, et al.
Thorax|March 15, 2015
A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lungArlene M A Glasgow, Donna M Small, Aaron Scott, et al.
Pageof 1